Xintian Chen

722 total citations
17 papers, 487 citations indexed

About

Xintian Chen is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Xintian Chen has authored 17 papers receiving a total of 487 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Immunology. Recurrent topics in Xintian Chen's work include Cancer-related gene regulation (6 papers), Epigenetics and DNA Methylation (5 papers) and RNA modifications and cancer (4 papers). Xintian Chen is often cited by papers focused on Cancer-related gene regulation (6 papers), Epigenetics and DNA Methylation (5 papers) and RNA modifications and cancer (4 papers). Xintian Chen collaborates with scholars based in China, France and India. Xintian Chen's co-authors include Zhongwei Li, Jin Bai, Junnian Zheng, Pingfu Hou, Minle Li, Sufang Chu, Diandian Wang, Yetao Tang, Ming Yuan and Meina Guo and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Chemosphere and Frontiers in Immunology.

In The Last Decade

Xintian Chen

16 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xintian Chen China 11 257 122 97 71 71 17 487
Tao Yue China 10 184 0.7× 82 0.7× 54 0.6× 42 0.6× 75 1.1× 28 641
Jie Long China 15 233 0.9× 101 0.8× 97 1.0× 70 1.0× 182 2.6× 32 687
Honghua Zhang China 17 229 0.9× 45 0.4× 87 0.9× 18 0.3× 48 0.7× 46 843
Jian‐Di Li China 11 156 0.6× 31 0.3× 109 1.1× 20 0.3× 28 0.4× 48 360
Zebin Hong China 13 102 0.4× 25 0.2× 65 0.7× 42 0.6× 24 0.3× 23 466
Suhnrita Chaudhuri India 12 148 0.6× 46 0.4× 43 0.4× 22 0.3× 73 1.0× 28 382
Xinglin Chen China 13 213 0.8× 19 0.2× 129 1.3× 58 0.8× 53 0.7× 32 587
Maryse Lemaire Canada 15 224 0.9× 12 0.1× 29 0.3× 43 0.6× 55 0.8× 21 562
Peter Leary Switzerland 11 102 0.4× 25 0.2× 17 0.2× 42 0.6× 45 0.6× 27 400

Countries citing papers authored by Xintian Chen

Since Specialization
Citations

This map shows the geographic impact of Xintian Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xintian Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xintian Chen more than expected).

Fields of papers citing papers by Xintian Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xintian Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xintian Chen. The network helps show where Xintian Chen may publish in the future.

Co-authorship network of co-authors of Xintian Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xintian Chen. A scholar is included among the top collaborators of Xintian Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xintian Chen. Xintian Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Shao, Zhiying, Xintian Chen, Tingting Tang, et al.. (2025). TRIM21-mediated PRMT1 degradation attenuates colorectal cancer malignant progression. Cell Death and Disease. 16(1). 56–56. 3 indexed citations
2.
Gao, Feifei, et al.. (2024). Functional roles of circular RNAs in lung injury. Frontiers in Pharmacology. 15. 1354806–1354806. 2 indexed citations
3.
Shen, Zhigang, Tao Dong, Hongmei Yong, et al.. (2024). FBXO22 promotes glioblastoma malignant progression by mediating VHL ubiquitination and degradation. Cell Death Discovery. 10(1). 151–151. 4 indexed citations
5.
Liu, Hao, et al.. (2024). PRMT1-mediated PGK1 arginine methylation promotes colorectal cancer glycolysis and tumorigenesis. Cell Death and Disease. 15(2). 170–170. 27 indexed citations
6.
Peng, Xiu, et al.. (2023). CircPRRC2C Promotes the Oncogenic Phenotypes of Laryngeal Squamous Cell Carcinoma Cells via MiR-136-5p/HOXD11 Axis. Molecular Biotechnology. 66(9). 2381–2395. 2 indexed citations
7.
Chen, Xintian, Hongmei Yong, Pengfei Wang, et al.. (2023). TRIM21 attenuates renal carcinoma lipogenesis and malignancy by regulating SREBF1 protein stability. Journal of Experimental & Clinical Cancer Research. 42(1). 34–34. 25 indexed citations
8.
Li, Zhongwei, Hongmei Yong, Wenwen Wang, et al.. (2022). GSK3326595 is a promising drug to prevent SARS‐CoV‐2 Omicron and other variants infection by inhibiting ACE2‐R671 di‐methylation. Journal of Medical Virology. 95(1). e28158–e28158. 12 indexed citations
9.
Chen, Xintian, Pengfei Wang, Sufang Chu, et al.. (2022). The emerging roles of TRIM21 in coordinating cancer metabolism, immunity and cancer treatment. Frontiers in Immunology. 13. 968755–968755. 24 indexed citations
10.
Chen, Xintian, Xueying Ji, Sen Meng, et al.. (2022). TRIM21 deficiency promotes cell proliferation and tumorigenesis via regulating p21 expression in ovarian cancer. Bioengineered. 13(3). 6024–6035. 14 indexed citations
11.
Li, Zhongwei, Diandian Wang, Xintian Chen, et al.. (2021). PRMT1-mediated EZH2 methylation promotes breast cancer cell proliferation and tumorigenesis. Cell Death and Disease. 12(11). 1080–1080. 42 indexed citations
12.
Chen, Xintian, Zhongwei Li, Hongmei Yong, et al.. (2021). Trim21-mediated HIF-1α degradation attenuates aerobic glycolysis to inhibit renal cancer tumorigenesis and metastasis. Cancer Letters. 508. 115–126. 58 indexed citations
13.
Chen, Xintian, Zhongwei Li, Xue Zhao, et al.. (2021). Role of Circular RNA in Kidney-Related Diseases. Frontiers in Pharmacology. 12. 615882–615882. 13 indexed citations
14.
Li, Zhongwei, Diandian Wang, Wenwen Wang, et al.. (2020). Macrophages-stimulated PRMT1-mediated EZH2 methylation promotes breast cancer metastasis. Biochemical and Biophysical Research Communications. 533(4). 679–684. 27 indexed citations
15.
Li, Zhongwei, Minle Li, Diandian Wang, et al.. (2020). Post-translational modifications of EZH2 in cancer. Cell & Bioscience. 10(1). 143–143. 58 indexed citations
16.
Liu, Wen‐Shen, Meina Guo, Chang Liu, et al.. (2018). Water, sediment and agricultural soil contamination from an ion-adsorption rare earth mining area. Chemosphere. 216. 75–83. 166 indexed citations
17.
Liu, Dan, Xiaoxi Li, Xintian Chen, et al.. (2018). Neural regulation of drug resistance in cancer treatment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1871(1). 20–28. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026